Janux Therapeutics Inc.
JANX | NASDAQ
$17.21
+$0.20 (+1.18%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 10.27M | 3.73M | 7.88M | 10M | n/a | n/a | n/a | 439K | 8.9M | 1.25M | 2.46M | 2.52M | 1.06M | 2.05M | 2.85M | 1.81M | 2.37M | 1.59M | 1.62M | 1.16M | 482K | 380K |
Cost of Revenue | n/a | 469K | 8.94M | 501K | 29.18M | 25.06M | 20.81M | 2.37M | 506K | 532K | 531K | 500K | 14.92M | 15.87M | 15.43M | 13.74M | 14.09M | 10.18M | 11.17M | 8.41M | 4.74M | 1.93M |
Gross Profit | 10.27M | 3.26M | -1.06M | 9.5M | -29.18M | -25.06M | -20.81M | -1.94M | 8.39M | 720K | 1.93M | 2.02M | -13.87M | -13.82M | -12.59M | -11.92M | -11.72M | -8.6M | -9.55M | -7.25M | -4.26M | -1.55M |
Operating Income | -31.69M | -34.21M | -42.4M | -35.25M | -45.12M | -34.9M | -29.02M | -35.84M | -13.82M | -20.16M | -16.14M | -15.81M | -20.75M | -20.28M | -18.27M | -18.02M | -17.26M | -13.54M | -13.49M | -10.9M | -6.25M | -2.28M |
Interest Income | 9.72M | 9.85M | 34.04M | 10.94M | 11.26M | 11.39M | 8.81M | 7.78M | 7.86M | 5.4M | 4.38M | 4.25M | 3.24M | 2.82M | 2.2M | 1.33M | 373K | 132K | 74K | 137K | 46K | n/a |
Pretax Income | -21.97M | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M | -10.77M | -6.21M | -2.28M |
Net Income | -21.97M | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M | -10.77M | -6.21M | -2.28M |
Selling & General & Admin | 10.96M | 11.13M | 10.85M | 10.12M | 10.45M | 9.84M | 8.22M | 17.67M | 7.32M | 6.81M | 6.36M | 6.44M | 6.88M | 6.46M | 5.68M | 6.1M | 5.54M | 4.95M | 3.94M | 3.66M | 2M | 739K |
Research & Development | 30.99M | 26.81M | 31.55M | 34.63M | 34.66M | 25.06M | 20.81M | 18.61M | 14.9M | 14.07M | 12.24M | 11.89M | 14.92M | 15.87M | 15.43M | 13.74M | 14.09M | 10.18M | 11.17M | 8.41M | 4.74M | 1.93M |
Other Expenses | n/a | -469K | -1.06M | n/a | -29.18M | -25.06M | -20.81M | -2.37M | n/a | n/a | -531K | -500K | -14.92M | -15.87M | -15.43M | -13.74M | -14.09M | -10.18M | -11.17M | -8.41M | -4.74M | -1.93M |
Operating Expenses | 41.96M | 37.48M | 41.34M | 44.75M | 15.94M | 9.84M | 8.22M | 33.91M | 22.21M | 20.88M | 18.07M | 17.83M | 6.88M | 6.46M | 5.68M | 6.1M | 5.54M | 4.95M | 3.94M | 3.66M | 2M | 739K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -506K | -532K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.96M | 37.95M | 50.28M | 45.25M | 45.12M | 34.9M | 29.02M | 36.28M | 22.72M | 21.41M | 18.6M | 18.33M | 21.81M | 22.33M | 21.11M | 19.84M | 19.63M | 15.13M | 15.11M | 12.06M | 6.73M | 2.66M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.94M | 62.67M | 61.97M | 62.02M | 61.9M | 61.79M | 56.83M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M | 41.13M | 10.03M | 39.9M |
Shares Outstanding (Diluted) | 62.94M | 62.67M | 61.97M | 62.02M | 61.9M | 61.79M | 56.83M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M | 41.13M | 10.03M | 39.9M |
EPS (Basic) | -0.35 | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.34 | -0.40 | -0.32 | -0.33 | -0.26 | -0.62 | -0.06 |
EPS (Diluted) | -0.35 | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.34 | -0.40 | -0.32 | -0.33 | -0.26 | -0.62 | -0.06 |
EBITDA | -21.97M | -23.89M | -31.43M | -23.81M | -33.32M | -22.99M | -19.7M | -27.55M | -5.45M | -14.23M | -11.23M | -11.07M | -17.04M | -17.01M | -15.66M | -16.45M | -16.78M | -13.33M | -13.35M | -10.74M | -6.19M | -2.28M |
EBIT | -21.97M | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M | -10.77M | -6.21M | -2.28M |
Depreciation & Amortization | n/a | 469K | 519K | 501K | 541K | 519K | 512K | 510K | 506K | 532K | 531K | 500K | 471K | 453K | 403K | 249K | 108K | 81K | 64K | 27K | 13K | 9K |
Add to Watchlist
Select watchlists to add or remove JANX